A recent study investigated the complex relationship between adiponectin, blood pressure, and metabolic function in obesity-associated hypertension. The study, conducted on 153 Chinese adults, analyzed adiponectin serum levels using ELISA across four distinct groups. Findings revealed that serum adiponectin levels were notably higher in the normal healthy group compared to the just-obesity group, with a negative correlation to the visceral adiposity index. Multiple linear regression analysis identified gender, serum albumin, alanine aminotransferase, and high-density lipoprotein cholesterol as significant independent correlates. The study suggests that various factors, including systemic metabolic signalling and impaired adiponectin clearance, influence the "adiponectin paradox" in obesity-related hypertension.
Like
Save
Share